nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—urinary bladder cancer	0.414	1	CbGbCtD
Brimonidine—AOX1—prostate gland—urinary bladder cancer	0.00667	0.111	CbGeAlD
Brimonidine—AOX1—seminal vesicle—urinary bladder cancer	0.00564	0.0935	CbGeAlD
Brimonidine—AOX1—renal system—urinary bladder cancer	0.00454	0.0754	CbGeAlD
Brimonidine—AOX1—urethra—urinary bladder cancer	0.00446	0.074	CbGeAlD
Brimonidine—ADRA2C—prostate gland—urinary bladder cancer	0.00421	0.0699	CbGeAlD
Brimonidine—AOX1—female reproductive system—urinary bladder cancer	0.00364	0.0604	CbGeAlD
Brimonidine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00356	0.0591	CbGeAlD
Brimonidine—ADRA2A—prostate gland—urinary bladder cancer	0.00336	0.0558	CbGeAlD
Brimonidine—AOX1—vagina—urinary bladder cancer	0.00329	0.0546	CbGeAlD
Brimonidine—ADRA2C—renal system—urinary bladder cancer	0.00287	0.0476	CbGeAlD
Brimonidine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00284	0.0472	CbGeAlD
Brimonidine—ADRA2C—urethra—urinary bladder cancer	0.00282	0.0468	CbGeAlD
Brimonidine—ADRA2A—urethra—urinary bladder cancer	0.00225	0.0373	CbGeAlD
Brimonidine—AOX1—lymph node—urinary bladder cancer	0.00213	0.0353	CbGeAlD
Brimonidine—ADRA2C—vagina—urinary bladder cancer	0.00208	0.0345	CbGeAlD
Brimonidine—ADRA2A—female reproductive system—urinary bladder cancer	0.00184	0.0304	CbGeAlD
Brimonidine—ADRA2A—vagina—urinary bladder cancer	0.00166	0.0275	CbGeAlD
Brimonidine—ADRA2C—lymph node—urinary bladder cancer	0.00135	0.0223	CbGeAlD
Brimonidine—ADRA2A—lymph node—urinary bladder cancer	0.00107	0.0178	CbGeAlD
Brimonidine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000857	0.00163	CcSEcCtD
Brimonidine—Infection—Fluorouracil—urinary bladder cancer	0.000854	0.00163	CcSEcCtD
Brimonidine—Osteoarthritis—Epirubicin—urinary bladder cancer	0.000851	0.00162	CcSEcCtD
Brimonidine—Myalgia—Cisplatin—urinary bladder cancer	0.00085	0.00162	CcSEcCtD
Brimonidine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000849	0.00162	CcSEcCtD
Brimonidine—Anxiety—Cisplatin—urinary bladder cancer	0.000847	0.00161	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000844	0.00161	CcSEcCtD
Brimonidine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000843	0.0016	CcSEcCtD
Brimonidine—Discomfort—Cisplatin—urinary bladder cancer	0.00084	0.0016	CcSEcCtD
Brimonidine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000839	0.0016	CcSEcCtD
Brimonidine—Face oedema—Epirubicin—urinary bladder cancer	0.000822	0.00156	CcSEcCtD
Brimonidine—Hypotension—Gemcitabine—urinary bladder cancer	0.000817	0.00155	CcSEcCtD
Brimonidine—Oedema—Cisplatin—urinary bladder cancer	0.000815	0.00155	CcSEcCtD
Brimonidine—Infection—Cisplatin—urinary bladder cancer	0.000809	0.00154	CcSEcCtD
Brimonidine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000804	0.00153	CcSEcCtD
Brimonidine—Lethargy—Doxorubicin—urinary bladder cancer	0.000804	0.00153	CcSEcCtD
Brimonidine—Hypotension—Fluorouracil—urinary bladder cancer	0.000803	0.00153	CcSEcCtD
Brimonidine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000799	0.00152	CcSEcCtD
Brimonidine—Cough—Etoposide—urinary bladder cancer	0.000798	0.00152	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000796	0.00152	CcSEcCtD
Brimonidine—Tachycardia—Cisplatin—urinary bladder cancer	0.000795	0.00151	CcSEcCtD
Brimonidine—Skin disorder—Cisplatin—urinary bladder cancer	0.000791	0.00151	CcSEcCtD
Brimonidine—Insomnia—Gemcitabine—urinary bladder cancer	0.000791	0.00151	CcSEcCtD
Brimonidine—Hypertension—Etoposide—urinary bladder cancer	0.00079	0.0015	CcSEcCtD
Brimonidine—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000788	0.0015	CcSEcCtD
Brimonidine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000785	0.00149	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000783	0.00149	CcSEcCtD
Brimonidine—Dry skin—Epirubicin—urinary bladder cancer	0.00078	0.00149	CcSEcCtD
Brimonidine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000779	0.00148	CcSEcCtD
Brimonidine—Chest pain—Etoposide—urinary bladder cancer	0.000779	0.00148	CcSEcCtD
Brimonidine—Insomnia—Fluorouracil—urinary bladder cancer	0.000777	0.00148	CcSEcCtD
Brimonidine—Somnolence—Gemcitabine—urinary bladder cancer	0.000777	0.00148	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000773	0.00147	CcSEcCtD
Brimonidine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000772	0.00147	CcSEcCtD
Brimonidine—Discomfort—Etoposide—urinary bladder cancer	0.000769	0.00146	CcSEcCtD
Brimonidine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000766	0.00146	CcSEcCtD
Brimonidine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000766	0.00146	CcSEcCtD
Brimonidine—Somnolence—Fluorouracil—urinary bladder cancer	0.000764	0.00145	CcSEcCtD
Brimonidine—Hypotension—Cisplatin—urinary bladder cancer	0.000761	0.00145	CcSEcCtD
Brimonidine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000761	0.00145	CcSEcCtD
Brimonidine—Face oedema—Doxorubicin—urinary bladder cancer	0.00076	0.00145	CcSEcCtD
Brimonidine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000757	0.00144	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000755	0.00144	CcSEcCtD
Brimonidine—Fatigue—Gemcitabine—urinary bladder cancer	0.000754	0.00143	CcSEcCtD
Brimonidine—Pain—Gemcitabine—urinary bladder cancer	0.000748	0.00142	CcSEcCtD
Brimonidine—Asthenia—Thiotepa—urinary bladder cancer	0.000746	0.00142	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000742	0.00141	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000742	0.00141	CcSEcCtD
Brimonidine—Infection—Etoposide—urinary bladder cancer	0.000742	0.00141	CcSEcCtD
Brimonidine—Influenza—Epirubicin—urinary bladder cancer	0.000736	0.0014	CcSEcCtD
Brimonidine—Pruritus—Thiotepa—urinary bladder cancer	0.000735	0.0014	CcSEcCtD
Brimonidine—Pain—Fluorouracil—urinary bladder cancer	0.000735	0.0014	CcSEcCtD
Brimonidine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000732	0.00139	CcSEcCtD
Brimonidine—Tachycardia—Etoposide—urinary bladder cancer	0.000729	0.00139	CcSEcCtD
Brimonidine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000726	0.00138	CcSEcCtD
Brimonidine—Skin disorder—Etoposide—urinary bladder cancer	0.000725	0.00138	CcSEcCtD
Brimonidine—Dry skin—Doxorubicin—urinary bladder cancer	0.000722	0.00137	CcSEcCtD
Brimonidine—Bronchitis—Epirubicin—urinary bladder cancer	0.000708	0.00135	CcSEcCtD
Brimonidine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000704	0.00134	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000703	0.00134	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—urinary bladder cancer	0.000701	0.00133	CcSEcCtD
Brimonidine—Depression—Methotrexate—urinary bladder cancer	0.000699	0.00133	CcSEcCtD
Brimonidine—Hypotension—Etoposide—urinary bladder cancer	0.000698	0.00133	CcSEcCtD
Brimonidine—Pain—Cisplatin—urinary bladder cancer	0.000697	0.00133	CcSEcCtD
Brimonidine—Dizziness—Thiotepa—urinary bladder cancer	0.000687	0.00131	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000681	0.0013	CcSEcCtD
Brimonidine—Influenza—Doxorubicin—urinary bladder cancer	0.000681	0.0013	CcSEcCtD
Brimonidine—Paraesthesia—Etoposide—urinary bladder cancer	0.00067	0.00128	CcSEcCtD
Brimonidine—Dyspnoea—Etoposide—urinary bladder cancer	0.000665	0.00127	CcSEcCtD
Brimonidine—Somnolence—Etoposide—urinary bladder cancer	0.000664	0.00126	CcSEcCtD
Brimonidine—Drowsiness—Epirubicin—urinary bladder cancer	0.000656	0.00125	CcSEcCtD
Brimonidine—Rash—Thiotepa—urinary bladder cancer	0.000655	0.00125	CcSEcCtD
Brimonidine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000655	0.00125	CcSEcCtD
Brimonidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000655	0.00125	CcSEcCtD
Brimonidine—Headache—Thiotepa—urinary bladder cancer	0.000651	0.00124	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000644	0.00123	CcSEcCtD
Brimonidine—Fatigue—Etoposide—urinary bladder cancer	0.000644	0.00123	CcSEcCtD
Brimonidine—Pain—Etoposide—urinary bladder cancer	0.000638	0.00122	CcSEcCtD
Brimonidine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000638	0.00121	CcSEcCtD
Brimonidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000633	0.00121	CcSEcCtD
Brimonidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000627	0.00119	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000625	0.00119	CcSEcCtD
Brimonidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000618	0.00118	CcSEcCtD
Brimonidine—Nausea—Thiotepa—urinary bladder cancer	0.000617	0.00118	CcSEcCtD
Brimonidine—Sinusitis—Epirubicin—urinary bladder cancer	0.000616	0.00117	CcSEcCtD
Brimonidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000608	0.00116	CcSEcCtD
Brimonidine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000607	0.00116	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—urinary bladder cancer	0.000606	0.00115	CcSEcCtD
Brimonidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0006	0.00114	CcSEcCtD
Brimonidine—Bradycardia—Epirubicin—urinary bladder cancer	0.0006	0.00114	CcSEcCtD
Brimonidine—Rhinitis—Epirubicin—urinary bladder cancer	0.00059	0.00112	CcSEcCtD
Brimonidine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00059	0.00112	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—urinary bladder cancer	0.000588	0.00112	CcSEcCtD
Brimonidine—Asthenia—Cisplatin—urinary bladder cancer	0.000585	0.00111	CcSEcCtD
Brimonidine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000585	0.00111	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000584	0.00111	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—urinary bladder cancer	0.000571	0.00109	CcSEcCtD
Brimonidine—Sinusitis—Doxorubicin—urinary bladder cancer	0.00057	0.00108	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000568	0.00108	CcSEcCtD
Brimonidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000568	0.00108	CcSEcCtD
Brimonidine—Visual impairment—Epirubicin—urinary bladder cancer	0.000568	0.00108	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000567	0.00108	CcSEcCtD
Brimonidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000555	0.00106	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—urinary bladder cancer	0.000551	0.00105	CcSEcCtD
Brimonidine—Rash—Gemcitabine—urinary bladder cancer	0.000551	0.00105	CcSEcCtD
Brimonidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000551	0.00105	CcSEcCtD
Brimonidine—Eye disorder—Epirubicin—urinary bladder cancer	0.00055	0.00105	CcSEcCtD
Brimonidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00055	0.00105	CcSEcCtD
Brimonidine—Erythema—Methotrexate—urinary bladder cancer	0.000548	0.00104	CcSEcCtD
Brimonidine—Headache—Gemcitabine—urinary bladder cancer	0.000548	0.00104	CcSEcCtD
Brimonidine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000547	0.00104	CcSEcCtD
Brimonidine—Flushing—Epirubicin—urinary bladder cancer	0.000547	0.00104	CcSEcCtD
Brimonidine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000546	0.00104	CcSEcCtD
Brimonidine—Rash—Fluorouracil—urinary bladder cancer	0.000542	0.00103	CcSEcCtD
Brimonidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000541	0.00103	CcSEcCtD
Brimonidine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000541	0.00103	CcSEcCtD
Brimonidine—Headache—Fluorouracil—urinary bladder cancer	0.000538	0.00103	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000536	0.00102	CcSEcCtD
Brimonidine—Asthenia—Etoposide—urinary bladder cancer	0.000536	0.00102	CcSEcCtD
Brimonidine—Angiopathy—Epirubicin—urinary bladder cancer	0.000534	0.00102	CcSEcCtD
Brimonidine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000532	0.00101	CcSEcCtD
Brimonidine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000531	0.00101	CcSEcCtD
Brimonidine—Pruritus—Etoposide—urinary bladder cancer	0.000528	0.00101	CcSEcCtD
Brimonidine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000526	0.001	CcSEcCtD
Brimonidine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000525	0.001	CcSEcCtD
Brimonidine—Nausea—Gemcitabine—urinary bladder cancer	0.000519	0.000988	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—urinary bladder cancer	0.000516	0.000983	CcSEcCtD
Brimonidine—Mental disorder—Epirubicin—urinary bladder cancer	0.000516	0.000982	CcSEcCtD
Brimonidine—Rash—Cisplatin—urinary bladder cancer	0.000514	0.000978	CcSEcCtD
Brimonidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000513	0.000977	CcSEcCtD
Brimonidine—Erythema—Epirubicin—urinary bladder cancer	0.000513	0.000976	CcSEcCtD
Brimonidine—Nausea—Fluorouracil—urinary bladder cancer	0.000511	0.000972	CcSEcCtD
Brimonidine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000509	0.000969	CcSEcCtD
Brimonidine—Flushing—Doxorubicin—urinary bladder cancer	0.000506	0.000963	CcSEcCtD
Brimonidine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000506	0.000963	CcSEcCtD
Brimonidine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000502	0.000956	CcSEcCtD
Brimonidine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000494	0.000941	CcSEcCtD
Brimonidine—Dizziness—Etoposide—urinary bladder cancer	0.000494	0.00094	CcSEcCtD
Brimonidine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000492	0.000937	CcSEcCtD
Brimonidine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000491	0.000935	CcSEcCtD
Brimonidine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000487	0.000927	CcSEcCtD
Brimonidine—Nausea—Cisplatin—urinary bladder cancer	0.000484	0.000921	CcSEcCtD
Brimonidine—Vision blurred—Epirubicin—urinary bladder cancer	0.000483	0.00092	CcSEcCtD
Brimonidine—Cough—Methotrexate—urinary bladder cancer	0.000478	0.00091	CcSEcCtD
Brimonidine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000477	0.000909	CcSEcCtD
Brimonidine—Erythema—Doxorubicin—urinary bladder cancer	0.000474	0.000903	CcSEcCtD
Brimonidine—Rash—Etoposide—urinary bladder cancer	0.000471	0.000896	CcSEcCtD
Brimonidine—Dermatitis—Etoposide—urinary bladder cancer	0.00047	0.000895	CcSEcCtD
Brimonidine—Headache—Etoposide—urinary bladder cancer	0.000468	0.00089	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—urinary bladder cancer	0.000466	0.000888	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—urinary bladder cancer	0.000466	0.000888	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000466	0.000888	CcSEcCtD
Brimonidine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000465	0.000884	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000463	0.000882	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—urinary bladder cancer	0.000461	0.000877	CcSEcCtD
Brimonidine—Syncope—Epirubicin—urinary bladder cancer	0.00046	0.000875	CcSEcCtD
Brimonidine—Palpitations—Epirubicin—urinary bladder cancer	0.000453	0.000862	CcSEcCtD
Brimonidine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000451	0.000858	CcSEcCtD
Brimonidine—Cough—Epirubicin—urinary bladder cancer	0.000447	0.000852	CcSEcCtD
Brimonidine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000447	0.000851	CcSEcCtD
Brimonidine—Infection—Methotrexate—urinary bladder cancer	0.000444	0.000846	CcSEcCtD
Brimonidine—Nausea—Etoposide—urinary bladder cancer	0.000443	0.000844	CcSEcCtD
Brimonidine—Hypertension—Epirubicin—urinary bladder cancer	0.000443	0.000843	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000438	0.000835	CcSEcCtD
Brimonidine—Arthralgia—Epirubicin—urinary bladder cancer	0.000436	0.000831	CcSEcCtD
Brimonidine—Chest pain—Epirubicin—urinary bladder cancer	0.000436	0.000831	CcSEcCtD
Brimonidine—Myalgia—Epirubicin—urinary bladder cancer	0.000436	0.000831	CcSEcCtD
Brimonidine—Anxiety—Epirubicin—urinary bladder cancer	0.000435	0.000828	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—urinary bladder cancer	0.000434	0.000827	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000433	0.000825	CcSEcCtD
Brimonidine—Discomfort—Epirubicin—urinary bladder cancer	0.000431	0.000821	CcSEcCtD
Brimonidine—Dry mouth—Epirubicin—urinary bladder cancer	0.000427	0.000813	CcSEcCtD
Brimonidine—Syncope—Doxorubicin—urinary bladder cancer	0.000425	0.00081	CcSEcCtD
Brimonidine—Palpitations—Doxorubicin—urinary bladder cancer	0.000419	0.000798	CcSEcCtD
Brimonidine—Oedema—Epirubicin—urinary bladder cancer	0.000418	0.000797	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—urinary bladder cancer	0.000418	0.000795	CcSEcCtD
Brimonidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000417	0.000794	CcSEcCtD
Brimonidine—Infection—Epirubicin—urinary bladder cancer	0.000416	0.000791	CcSEcCtD
Brimonidine—Cough—Doxorubicin—urinary bladder cancer	0.000414	0.000788	CcSEcCtD
Brimonidine—Shock—Epirubicin—urinary bladder cancer	0.000412	0.000784	CcSEcCtD
Brimonidine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00041	0.000781	CcSEcCtD
Brimonidine—Hypertension—Doxorubicin—urinary bladder cancer	0.00041	0.00078	CcSEcCtD
Brimonidine—Tachycardia—Epirubicin—urinary bladder cancer	0.000408	0.000777	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000407	0.000775	CcSEcCtD
Brimonidine—Skin disorder—Epirubicin—urinary bladder cancer	0.000406	0.000774	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—urinary bladder cancer	0.000404	0.00077	CcSEcCtD
Brimonidine—Chest pain—Doxorubicin—urinary bladder cancer	0.000404	0.000769	CcSEcCtD
Brimonidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000404	0.000769	CcSEcCtD
Brimonidine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000404	0.000769	CcSEcCtD
Brimonidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000402	0.000766	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000401	0.000764	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000401	0.000764	CcSEcCtD
Brimonidine—Discomfort—Doxorubicin—urinary bladder cancer	0.000399	0.00076	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000399	0.000759	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—urinary bladder cancer	0.000397	0.000757	CcSEcCtD
Brimonidine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000395	0.000752	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000394	0.000749	CcSEcCtD
Brimonidine—Hypotension—Epirubicin—urinary bladder cancer	0.000391	0.000744	CcSEcCtD
Brimonidine—Oedema—Doxorubicin—urinary bladder cancer	0.000387	0.000737	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000386	0.000735	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—urinary bladder cancer	0.000385	0.000734	CcSEcCtD
Brimonidine—Infection—Doxorubicin—urinary bladder cancer	0.000385	0.000732	CcSEcCtD
Brimonidine—Pain—Methotrexate—urinary bladder cancer	0.000382	0.000728	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000381	0.000726	CcSEcCtD
Brimonidine—Shock—Doxorubicin—urinary bladder cancer	0.000381	0.000725	CcSEcCtD
Brimonidine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00038	0.000723	CcSEcCtD
Brimonidine—Insomnia—Epirubicin—urinary bladder cancer	0.000378	0.00072	CcSEcCtD
Brimonidine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000378	0.000719	CcSEcCtD
Brimonidine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000376	0.000716	CcSEcCtD
Brimonidine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000376	0.000715	CcSEcCtD
Brimonidine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000373	0.00071	CcSEcCtD
Brimonidine—Somnolence—Epirubicin—urinary bladder cancer	0.000372	0.000708	CcSEcCtD
Brimonidine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000368	0.000701	CcSEcCtD
Brimonidine—Hypotension—Doxorubicin—urinary bladder cancer	0.000362	0.000689	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000361	0.000688	CcSEcCtD
Brimonidine—Fatigue—Epirubicin—urinary bladder cancer	0.000361	0.000687	CcSEcCtD
Brimonidine—Pain—Epirubicin—urinary bladder cancer	0.000358	0.000681	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000353	0.000671	CcSEcCtD
Brimonidine—Insomnia—Doxorubicin—urinary bladder cancer	0.00035	0.000667	CcSEcCtD
Brimonidine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000348	0.000662	CcSEcCtD
Brimonidine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000345	0.000657	CcSEcCtD
Brimonidine—Somnolence—Doxorubicin—urinary bladder cancer	0.000344	0.000655	CcSEcCtD
Brimonidine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000341	0.000649	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000334	0.000636	CcSEcCtD
Brimonidine—Fatigue—Doxorubicin—urinary bladder cancer	0.000334	0.000635	CcSEcCtD
Brimonidine—Pain—Doxorubicin—urinary bladder cancer	0.000331	0.00063	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000329	0.000627	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—urinary bladder cancer	0.000321	0.000611	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—urinary bladder cancer	0.000316	0.000602	CcSEcCtD
Brimonidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000308	0.000587	CcSEcCtD
Brimonidine—Asthenia—Epirubicin—urinary bladder cancer	0.0003	0.000571	CcSEcCtD
Brimonidine—Pruritus—Epirubicin—urinary bladder cancer	0.000296	0.000564	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—urinary bladder cancer	0.000296	0.000563	CcSEcCtD
Brimonidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000285	0.000543	CcSEcCtD
Brimonidine—Rash—Methotrexate—urinary bladder cancer	0.000282	0.000537	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000282	0.000536	CcSEcCtD
Brimonidine—Headache—Methotrexate—urinary bladder cancer	0.00028	0.000533	CcSEcCtD
Brimonidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000278	0.000529	CcSEcCtD
Brimonidine—Dizziness—Epirubicin—urinary bladder cancer	0.000277	0.000527	CcSEcCtD
Brimonidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000274	0.000521	CcSEcCtD
Brimonidine—Nausea—Methotrexate—urinary bladder cancer	0.000266	0.000506	CcSEcCtD
Brimonidine—Rash—Epirubicin—urinary bladder cancer	0.000264	0.000502	CcSEcCtD
Brimonidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000264	0.000502	CcSEcCtD
Brimonidine—Headache—Epirubicin—urinary bladder cancer	0.000262	0.000499	CcSEcCtD
Brimonidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000256	0.000487	CcSEcCtD
Brimonidine—Nausea—Epirubicin—urinary bladder cancer	0.000249	0.000473	CcSEcCtD
Brimonidine—Rash—Doxorubicin—urinary bladder cancer	0.000244	0.000465	CcSEcCtD
Brimonidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000244	0.000464	CcSEcCtD
Brimonidine—Headache—Doxorubicin—urinary bladder cancer	0.000243	0.000462	CcSEcCtD
Brimonidine—Nausea—Doxorubicin—urinary bladder cancer	0.00023	0.000438	CcSEcCtD
